NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $99 | -58.9% | 2,242 | -54.8% | 0.00% | – |
Q2 2023 | $241 | -99.9% | 4,960 | -29.3% | 0.00% | – |
Q3 2022 | $307,000 | -75.2% | 7,012 | -77.0% | 0.00% | -100.0% |
Q1 2022 | $1,240,000 | +12300.0% | 30,483 | +34539.8% | 0.00% | – |
Q3 2021 | $10,000 | +11.1% | 88 | 0.0% | 0.00% | – |
Q2 2021 | $9,000 | -80.9% | 88 | -81.3% | 0.00% | – |
Q1 2021 | $47,000 | -91.2% | 470 | -93.7% | 0.00% | -100.0% |
Q3 2020 | $536,000 | +53500.0% | 7,424 | +28453.8% | 0.00% | – |
Q2 2020 | $1,000 | -98.9% | 26 | -99.2% | 0.00% | – |
Q1 2020 | $91,000 | -83.3% | 3,076 | -81.0% | 0.00% | -100.0% |
Q4 2019 | $544,000 | +635.1% | 16,157 | +615.2% | 0.00% | – |
Q3 2019 | $74,000 | -17.8% | 2,259 | -31.0% | 0.00% | – |
Q2 2019 | $90,000 | +164.7% | 3,274 | +94.8% | 0.00% | – |
Q1 2019 | $34,000 | +240.0% | 1,681 | +130.6% | 0.00% | – |
Q4 2018 | $10,000 | -69.7% | 729 | -48.6% | 0.00% | – |
Q3 2018 | $33,000 | -77.9% | 1,419 | -82.1% | 0.00% | -100.0% |
Q2 2018 | $149,000 | +109.9% | 7,922 | -0.2% | 0.00% | -66.7% |
Q4 2017 | $71,000 | -29.7% | 7,938 | +1.3% | 0.00% | -25.0% |
Q3 2017 | $101,000 | +818.2% | 7,839 | +497.9% | 0.00% | – |
Q1 2017 | $11,000 | 0.0% | 1,311 | +28.2% | 0.00% | -100.0% |
Q3 2016 | $11,000 | +1000.0% | 1,023 | +564.3% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 154 | +29.4% | 0.00% | – |
Q4 2015 | $1,000 | – | 119 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |